GlassScriptPhysician profile
Gary Karakashian
NPI 1649227174
$1,250.14
in general payments reported to CMS, 2019-2025
20 companies · $74.17 in 2025
The $74.17 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.47 · 2020: $218 · 2021: $376 · 2022: $124 · 2023: $187 · 2024: $176 · 2025: $74.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $353.28 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $184.96 | 2019-2025 | Odomzo, Blu-U |
| Galderma Laboratories, L.P. | $152.13 | 2019-2025 | Nemluvio |
| Leo Pharma INC. | $131.15 | 2019-2021 | |
| Abbvie INC. | $130.69 | 2023-2024 | |
| Biofrontera INC. | $38.73 | 2020-2021 | |
| Pfizer INC. | $38.29 | 2023 | |
| Mayne Pharma Commercial LLC | $28.93 | 2019-2020 | |
| Genzyme Corporation | $19.67 | 2023 | |
| Lilly USA, LLC | $18.63 | 2025 | Ebglyss |
| Regeneron Healthcare Solutions, INC. | $18.44 | 2025 | Libtayo |
| Convatec INC. | $17.48 | 2024 | |
| Bioventus LLC | $17.28 | 2022 | |
| Janssen Biotech, INC. | $17.00 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.00 | 2023 | Nuzyra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $14.74 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.59 | 2024 | Cabtreo |
| Merck Sharp & Dohme LLC | $14.34 | 2019 | |
| Strata Skin Sciences, INC. | $12.60 | 2019 | |
| Epi Health, LLC | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Karakashian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.